If a Marketing Authorization Holder (MAH) nurtures a molecule and gives it a proper shape in form of a palatable dosage form with various types, i.e., in different strengths and route of administration(s), they also are required to keep a track-record of how the product is behaving in pharmacokinetic, pharmacodynamic and more so, pharmacogenetic pattern, once marketed.
Documenting and routing of all the product related inquiries can aid in analysis of product trend eventually with a span of its time spent in market. Simply adverse event monitoring is not a sufficient measure to comply to this dire need and the issues faced are to be addressed on a wider platform, also termed as Product information/inquiry evaluation and response.